carvedilol has been researched along with Goldblatt Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Huang, C; Huang, Q; Xu, L; Zhang, B | 1 |
| Benck, U; Diehl, S; Krämer, BK; Mircheva, M; Rathmann, N | 1 |
2 other study(ies) available for carvedilol and Goldblatt Syndrome
| Article | Year |
|---|---|
The effects of carvedilol on cardiac structural remodeling: the role of endogenous nitric oxide in the activity of carvedilol.
Topics: Animals; Blood Pressure; Carbazoles; Carvedilol; Heart; Hypertension, Renovascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Rats; Renal Artery; Ventricular Remodeling | 2013 |
[A 93-year-old patient with hypertensive crises and renal failure due to bilateral renal artery stenosis].
Topics: Aged, 80 and over; Angioplasty; Carbazoles; Carvedilol; Combined Modality Therapy; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertension, Renovascular; Life Style; Propanolamines; Ramipril; Renal Artery Obstruction; Stents; Weight Loss | 2015 |